2022 Blue Planet Prize: Announcement of Prize Winners - THE ASAHI GLASS FOUNDATION
This year marks the 31st awarding of the Blue Planet Prize, the international environmental award sponsored by the Asahi Glass Foundation, chaired by Takuya Shimamura. Every year, the Foundation selects two winners, individuals or organizations who have made significant contributions to the resolution of global environmental problems. The Board of Directors have selected the following 2022 Blue Planet Prize recipients.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220608006214/en/
2022 recipients: (1) His Majesty Jigme Singye Wangchuck, the Fourth King of Bhutan; (2) Professor Stephen Carpenter (USA) (Graphic: Business Wire)
2022 recipients
His Majesty Jigme Singye Wangchuck, the Fourth King of Bhutan
Born in the Kingdom of Bhutan, Date of Birth: 11 November, 1955
His Majesty Jigme Singye Wangchuck, the Fourth King of Bhutan, is the visionary leader who introduced the development philosophy of Gross National Happiness (GNH) which places the well being of the people at the heart of development activities and programmes. GNH gives importance to environmental conservation, sustainable and equitable development, and promotion of culture and social values which contribute to collective happiness. Using happiness as a social indicator was taken on by the United Nations and OECD also employed it in their reports, giving inspiration for an alternative paradigm to modern society.
Professor Stephen Carpenter (USA)
Born in the USA, Date of Birth: 5 July, 1952
Emeritus Director of the Center for Limnology,
Stephen Alfred Forbes Professor Emeritus of Integrative Biology, University of Wisconsin-Madison
Professor Stephen Carpenter has conducted research on lake ecosystems for more than 40 years. Through his research on lake eutrophication, from nutrients such as phosphorus and nitrogen, he studied the resilience of lakes using mathematical models, providing a new perspective on social-ecological systems. He also worked on the environmental pollution from phosphorus and nitrogen through land use, showing the critical state of the global phosphorus cycle and the need to review human activity from a broad geochemical viewpoint.
Each recipient is presented with a certificate of merit, a commemorative trophy, and 50 million Japanese yen in prize money.
We would like to hold the Blue Planet Prize Award Ceremony and commemorative lectures, which could well be on a smaller scale, while taking proper measures to prevent infection with the new coronavirus. The Award Ceremony is scheduled on Wednesday, October 5, 2022 at Tokyo Kaikan. Commemorative lectures will be given on October 6 and 8, 2022, at the University of Tokyo and at Kyoto University, respectively.
This press release and the photo of each recipient will be published 11 a.m. on Wednesday June 15 on the website of the Asahi Glass Foundation (www.af-info.or.jp/en).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220608006214/en/
Contact information
THE ASAHI GLASS FOUNDATION
Toshihiro Tanuma, PhD
TEL: +81 3 5275 0620
FAX: +81 3 5275 0871
E-mail: post@af-info.or.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe's GetVocal raises $26m to scale trustworthy conversational agents for enterprises18.11.2025 11:00:00 EET | Press release
GetVocal, Europe’s leading provider of conversational AI agents for enterprise customer support, today announced the closing of a $26 million Series A investment round led by Creandum with participation from Elaia and Speedinvest, bringing GetVocal’s total fundraising to $30 million. GetVocal will use the funding to fuel product innovation, market expansion, and hiring across Europe as the company accelerates its mission to help enterprises build hybrid human-AI workforces. Founded in 2023 by AI entrepreneurs Roy Moussa and Antonin Bertin, GetVocal is headquartered in Paris, with a 60-strong team spread across Europe. It serves 23 markets, with a stronghold in France and Portugal, and a rapidly growing presence in the UK and DACH. The company tackles one of the biggest barriers to conversational AI adoption – the lack of trust and confidence in black-box autonomous systems – by building trustworthy, transparent, and governed AI agents that accelerate the customer experience (CX) market
Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 10:05:00 EET | Press release
Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio
SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 10:00:00 EET | Press release
SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive long-term growth. “We are thrilled to welcome Oliver to SkySparc’s leadership team,” said Jo
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 09:23:00 EET | Press release
Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline infusion preparation, reduce healthcare professionals’ workload, and support hospital operational efficiency.3 The Remsima™ IV liquid formulation is approved in the EU for all indications of IV infliximab, matching the approved uses of all existing IV infliximab powder formulations, including rheumatoid arthritis (RA), adult and pediatric Crohn’s disease (CD), ulcerative colitis (UC), pediatric UC, ankylosing spondylitis (AS), psoriatic arthritis (PsA), and psoriasis (PsO).1 The comparability between lyophilized powder formulation and the liquid formulation of IV infliximab has been established through comprehensive chemistry, manufacturing, and controls data.2 The stability of the liquid formulation of I
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 09:00:00 EET | Press release
Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approaches for combating cancer. IDEAL Japan follows the conclusion of the highly respected JCA (Japanese Cancer Association) Mauvernay Award in Japan, which honored Japanese scientists over the last 20 years, from 2004 through 2024. Debiopharm is now transitioning its historic award into the IDEAL Japan initiative aiming to accelerate preclinical scientific research that could give rise to new treatments for cancer patients. “Our vision is to collaborate to find a cure for cancer,”explained Thierry Mauvernay, President of Debiopharm. “We believe that our ongoing Swiss-Japanese connection needs to evolve and catalyze the trans
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
